Non-small cell lung cancer (NSCLC) remains the most prevalent type of lung cancer and a leading cause of cancer-related mortality worldwide. Surgical ...

MIT-alumni-founded Thermedical advances novel deep-tissue ablation technology to address critical unmet needs in severe ventricular tachycardia ...

Earlier this year our Cath Lab electrophysiology team, led by Dr. Albert Sey, completed their first procedure using the ...

Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.

Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...

AtriCure announced the successful first-in-human AFib treatments using its novel dual-energy surgical cardiac ablation platform.

BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF ...

( Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced ...

Catheter ablation significantly reduces cardiovascular risks and mortality in patients with both atrial fibrillation and obstructive sleep apnea. The study involved over 18,000 patients, showing a ...

Obstructive sleep apnea is associated with increased atrial fibrillation recurrence after ablation in patients with paroxysmal atrial fibrillation.

HCA Healthcare UK has introduced Medtronic’s Affera mapping and ablation system at The Harley Street Clinic, becoming the ...

A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.